Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
COVID-19 관련 뇌병증에서 정맥 면역글로불린 요법
Original Communication
[키워드] adverse event
adverse events
age
Agitation
all subjects
anti-cytokine
anti-inflammatory action
brain MRI
Case series
case sery
cell count
clinical
Clinical efficacy
collected data
commenced
Complete
COVID-19
CSF
CSF analysis
delirium
demonstrated
disease course
driven by
effective
Efficacy
Efficacy and safety
Encephalopathy
extrapyramidal
females
hospital
Hospitalized
Immunoglobulin
impaired consciousness
initial
Intravenous immunoglobulin
Invasive mechanical ventilation
Italian
IVIG
manifestation
neurological manifestations
Neuropsychiatric
non-specific
objective
Patient
patients
patients with COVID-19
preliminary finding
protein levels
required
respiratory distress
Result
RT-PCR
Safe
SARS-CoV-2
Severe respiratory distress
suffered
supplementary material
Symptom
tested
therapy
treated
Treatment
[DOI] 10.1007/s00415-020-10248-0 PMC 바로가기 [Article Type] Original Communication
[DOI] 10.1007/s00415-020-10248-0 PMC 바로가기 [Article Type] Original Communication